(Q33799253)

29 July 2017

1 reference

title

Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? (English)

1 reference

29 July 2017

1 reference

Gentilini P

1

1 reference

29 July 2017

Laffi G

2

1 reference

29 July 2017

La Villa G

3

1 reference

29 July 2017

Romanelli RG

4

1 reference

29 July 2017

Blendis LM

5

1 reference

29 July 2017

publication date

1 December 1999

1 reference

29 July 2017

published in

Journal of Hepatology

1 reference

29 July 2017

volume

31

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

1088-1097

1 reference

Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Compensated cirrhosis: Natural history and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

KINETICS OF PERITONEAL FLUID ABSORPTION IN ADULT MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Functional renal alterations in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Pathophysiology and treatment of ascites and the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Hepatitis C associated glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

1 reference

7 January 2021

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Splanchnic hemodynamics in chronic portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Hemodynamic effects of glucagon in portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Pattern of sodium handling and its consequences in patients with preascitic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Renal response to a saline load in well-compensated alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Role of vasopressin in abnormal water excretion in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Metabolic clearance rate of arginine vasopressin in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Increased plasma levels of substance P and disturbed water excretion in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Renal failure in the patient with cirrhosis. The role of active vasoconstriction.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Renal and intrarenal blood-flow in cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Prognostic value of spontaneous hyponatremia in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Plasma human atrial natriuretic factor in cirrhosis and ascites with and without functional renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

The response of atrial natriuretic factor and sodium excretion to dietary sodium challenges in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Effects of peritoneovenous shunting on body composition

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Plasma levels of brain natriuretic peptide in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Mechanisms of action of atrial natriuretic factor and C-type natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Natriuretic peptides: are these new links in the hepatorenal connections?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Increased adrenomedullin levels in cirrhosis: Relationship with hemodynamic abnormalities and vasoconstrictor systems

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Urinary excretion of urodilatin in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Altered renal and platelet arachidonic acid metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Renal Kallikrein Excretion in Cirrhotics with Ascites: Relationship to Renal Hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Increased production of cysteinyl leukotrienes in hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

The effects of endotoxin on platelet-activating factor synthesis in cultured rat glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Regulatory functions of the vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Hypoxia of the renal medulla--its implications for disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980324-9

7 January 2021

10.1016/S0168-8278(99)80324-9

Identifiers

DOI

1 reference

29 July 2017

1 reference